Nursing evaluation during treatment with helmet CPAP in patients with respiratory failure due to COVID-19 pneumonia: A case series

Privitera, Daniele; Capsoni, Nicolò; Mazzone, Annamaria; Airoldi, Chiara; Angaroni, Laura; Pierotti, Federico; Rocca, Eugenia; Dal Molin, Alberto; Bellone, Andrea

Background During COVID-19 outbreak, with the increasing number of patients presenting with acute respiratory failure, a large use of non-invasive positive pressure ventilation was done in the emergency departments and medical wards despite the lack of recommendations. This study describes the clinical characteristics of patients presenting to the hospital with acute respiratory failure due to COVID-19 related pneumonia undergoing treatment with helmet CPAP with a strict nursing evaluation and monitoring. Methods A case series study enrolling adult patients admitted to an emergency department of an Italian hospital with acute respiratory failure due to COVID-19 pneumonia from March 18th to April 18th, 2020, was conducted. Only patients who strictly followed a local CPAP protocol were enrolled. Results A total of 52 patients were included in this study. 38 patients (73%) were judged eligible for endotracheal intubation (ETI). Eight-teen (34.6%) were intubated. Six-teen (30.8%) patients died: 7 (38.9%) and 9 (26.5%) in the eligible and non-eligible for ETI group, respectively. The median hospital length of stay was different in ETI and non-ETI group: 26 days [IQR 16-37] vs 15 days [IQR 9-17] (p = 0.005). The median invasive mechanical ventilation time was 11 days [IQR 7-21] with an ICU length of stay of 14.5 days [IQR 10-28]. During the CPAP trial, among patients eligible for ETI variations over time for positive end-expiratory pressure (p = 0.003) and respiratory rate (p = 0.059) were found between intubated and non-intubated patients. Conclusions A short closed monitored CPAP trial could be considered for acute respiratory failure due to COVID-19 pneumonia before considering ETI. A progressive positive end-expiratory pressure titration should target patient’s respiratory rate reduction. More studies are needed to evaluate the efficacy and predictors of failure of CPAP and non-invasive positive pressure ventilation in patients with acute respiratory failure due to COVID-19 pneumonia.